RecruitingNCT06038019
Thresholds In Food Allergy evaluaTion And predictioN
Thresholds In Food Allergy evaluaTion And predictioN, a Prospective, Multicentre Registry Study
Sponsor
Hamilton Health Sciences Corporation
Enrollment
2,000 participants
Start Date
Nov 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Thresholds In food allergy evaluaTion And predictioN, a prospective, observational registry. The aim is to quantify food allergy thresholds in Canada and their clinical predictors.
Eligibility
Min Age: 3 MonthsMax Age: 65 Years
Inclusion Criteria2
- Suspicion or history of food allergy based on medical history, positive skin prick test, and/or serum food-specific IgE. A suggestive history is defined as typical clinical signs and/or symptoms (urticaria, angioedema, abdominal pain, vomiting, dyspnea, wheeze) within 60 minutes of the ingestion of a food.
- Ability to discontinue all antihistamines for 1 week before oral food challenge.
Exclusion Criteria4
- Previous desensitization treatment to a food allergen
- Allergies to any component of the oral challenge vehicle
- Unstable conditions including uncontrolled asthma or chronic urticaria
- Any clinically significant disease/chronic medical condition which may interfere with study evaluations.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTOral food challenge
Patients will undergo oral food challenge with increasing amounts of food allergen
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06038019
Related Trials
Natural History and Genetics of Food Allergy and Related Conditions
NCT025048531 location
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
NCT072125301 location
Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children
NCT064679941 location
Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy
NCT063806735 locations
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
NCT063694677 locations